Skip to content

Author

Qing-Hua Yin

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Histone Lactylation-mediated PKM2 promotes gemcitabine resistance in pancreatic adenocarcinoma via the AKT/mTOR/SREBP1 Axis.

BACKGROUND Pancreatic adenocarcinoma (PAAD) is a highly malignant tumor. The efficacy of its first-line chemotherapeutic agent, gemcitabine (GEM), is frequently compromised by acquired resistance. Although pyruvate kinase M2 (PKM2) is a potential target for mitigating GEM resistance, the underlying mechanism remains un...

Qing-Hua Yin, Yang Zhou, Kai Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.